SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-004821
Filing Date
2018-05-08
Accepted
2018-05-08 07:37:29
Documents
2
Period of Report
2018-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tgtx8-kreresultsofoperati.htm 8-K 23838
2 EX-99.1 v050817_ex99-1.htm EX-99.1 82381
  Complete submission text file 0001654954-18-004821.txt   107649
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 18812972
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences